1.TCM Treatment for Complications due to Peritoneal Dialysis in Chronic Renal Failure
Lianbo WEI ; Rengao YE ; Huiqun LI
Journal of Traditional Chinese Medicine 1993;0(04):-
Complications in CRF-CAPD were treated by TCM during the past 17 years. Loss of appetite and hypoproteinemia were treated with modified Renshen Yangrong Decoction, for abdominal pain and distention, modified Xiangsha Liujunzi Decoction; for peritonitis, modified Dacaihu Decoction; for diarrhea due to hypofunction of spleen with exuberant dampness, modified Shenling Baizhu Powder; for Yang-deficiency of the Spleen and Kidney, modified Lizhong Decoction plus Sishen Pill; for skin pruritus, Siwu Decoction with additives; for renal -ortheopathy, treated by principles of tonifying the liver - kidney, strengthening the bones and tendons and blood - activating and stasis - relieving; for hyperlipidemia, by principles of tonifying the liver -kidney, phlegm and turbidity - eliminating and blood - activating stasis - relieving; for renalanemia, Guishao Sijunzi Decoction with additives. To improve patient'sliving quality and nutrition, self- formulated Shentekang capsule was given to improve renal function, decrease the frequencies and duration of dialysis, self - formulated Shenshuai Recipe was administered.
2.Activation of NF-? B Signaling Pathway in Peripheral Blood Mononuclear Cells of Patients With Systemic Lupus Erythematosus
Hanshi XU ; Rengao YE ; Lin SUN
Chinese Journal of Dermatology 1995;0(01):-
Objective To detect the activation of NF-? B signaling pathway in peripheral blood mononuclear cells(PBMCs) of patients with systemic lupus erythematosus(SLE) and investigate its clinical significance. Methods Activation of NF-? B was detected by electrophoretic mobility shift assay( EMSA), the expression of I? B? protein and its phosphorylated products were detected by Western blot. Anti-dsDNA antibody, IgG and IgM in supernatant of PBMC culture were tested by ELISA. Results (1)Elevated activation of NF-? B in PBMC of SLE patients was found when compared with the controls(P
3.Acute Renal Failure in Idiopathic Nephrotic Syndrome
Zhu HAN ; Rengao YE ; Qing XIANG
Journal of Chinese Physician 2001;0(03):-
Objective To study clinical feature,pathology,treatment and outcome of acute renal failure(ARF) in idiopathic nephrotic syndrome(IDNS).Methods History-taking of 38 cases were carried out all detailly 24-hour urine protein,biochemistry markers,hemorheology,renal histopathology were detected.Results The study fandings that 82 percent of patients were less than 40 years old,76 3 percent were male,74 percent(28 patients) were non-oliguria and 52 6 percent were minimal change glomerulonephritis through the renipuncture,most of the cases had edema of interstitium, by give prednisone of standard dosage,symptomatic treatment or dialysis the satisfying efficacy was got.Conclusions The main features of IDNS complicated with ARF are usual,it is non-oliguria type in clinic minimal glomerulonephritis in pathology,and deficient blood volume leads to occurrence of ARF,but the renal function could be recovered by give prednisone of routine dosage,symptomatic treatment and hemodialysis therapy.
4.Ethics of withdrawal dialysis
xing WU ; Rengao YE ; Ying WANG ;
Chinese Medical Ethics 2001;(1):55-56
Objective To investigate the value of dialysis and ethics of withdrawal dialysis.Method Through analysis of some typical cases of ESRD patients,to investigate the value of dialysis.Conclusion A lot of ESRD patients can survive through dialysis,thanks to the improvement of medical science in last 30 years.On the other hand,it can also keep some patients with no living calculation surviving,becoming the burdensome of families,hospitals and societies.Our object is to discuss the ethics of withdrawal dialysis in our country.
5.EVALUATION OF PROTEIN DETERMINATION IN URINE FOR GLOMERULAR HEMATURIA DIAGNOSIS
Jianhui ZHONG ; Rengao YE ; Chengjin LI ;
Chinese Journal of Nephrology 1994;0(04):-
To study the affection of blood on protein determining in urine, different volumes of blood from healthy volunteers was added to urine samples of varied osmolatites. Specimens were analyzed for protein concentration by the method of 3% sulfosalicylic acid. Microscopic hematuria was not associated proteinuria. In hypertonic urines, the protein of gross hematuria is low (30mg/100ml for the urine with 3% RBC, 32. 4mg/100ml for the urine with 1% blood), while in iso and hypotonic urines gross hematuria produced marked proteinuria (225—1090mg/100ml). Urine protein electrophoreses identified hemoglobin as the responsible protein. The protein concentration in urine may he used to distinguish glomerular hematuria from nonglomerular hematuria.
7.Diagnostic significance of lupus band test in systemic lupus erythematosus
Qunying GUO ; Rengao YE ; Junzhou FU ;
Chinese Journal of Rheumatology 2001;0(02):-
0 05).Of patients with lupus renal lesions 86% had a positive LBT (+LBT),which was significantly higher than that of patients without renal lesions(37%) ( P
8.Comparison of growth and apoptosis of fibroblasts derived from kidneys with and without interstitial fibnwis
Guoqiang ZHENG ; Rengao YE ; Yongxinng CHENG
Chinese Journal of Nephrology 1994;0(02):-
Objective To study the role of fibroblasts in the pathomechanisms of renal interstitial fibrosis(RIF). Methods Growth behavior and apoptos, of renal interstitial fibroblasts in cultures, established using renal biopsies of casts with and without RIF, were studied. Results There were significant alterations in the growth behavior, the differentiation pattern of potentially mitotic fibroblast populations and programmed cell death in cultures derived from kidneys with RIF, as compared with cultures of normal origin. Conclusion The abnormal growth and apoptosis of fibroblasts may play an im-portant role in RIF. Inhibiting the proliferation and promoting the programmed death of fibroblasts may be benificial to patients with RIF.
9.Study on intermittence and dosage of CTX pulse treatment on lupus nephritis
Guanxian LIU ; Rengao YE ; Xiaoling MAO
Chinese Journal of Nephrology 1997;0(05):-
To investigate the best intennittence and reasonable dosage of CDC pulse therapy on different activity degree of lupus nephritis (LN). Methods 96 severe LN cases were divided into three groups. Croup A; CTX pusle treatment (IV-CTX), once 2 weeks, 8- 12 mg'kg'Vd for two days; Group B: IV-CTX once a month, 0.5 - 1.0/m2; Group C: IV-CTX once 3 months, 0.5 - 1.0/m2. Prednisone was given to three groups simultaneously. Results The time taking effect was shorter significantly in Group A than that in Group B and C. Remission rate was higher significantly in Group A than that in Group B and C ( P 0. 05). Intermittence of 15 cases (23.8%) from Group Ek C was changed to once 2 weeks and then the disease activity had been controlled since these patients became worse during the treatment. Intennittence of 3 patients (9% ) from Group A was delayed a week because of the decreasing of WBC counting. There was no significantly difference between three groups in side effect and its incidence. Conclusion A reasonable IV-CTX should be choosen according to the disease activity. IV-CTX 8 - 12 mg'kg'Vd for two days, once 2 weeks should be used for acute and severe LN. When disease becomes mild, IV-CTX can be changed to 0.5 - 1.0/m2, once a month. After LN activity is controlled basically, 0.5- 1.0/m2, once a month is recommended.
10.Long-term survey on reversible uremia in patients with lupus nephritis
Xiaoping LI ; Xionggen LI ; Rengao YE
Chinese Journal of Nephrology 1997;0(06):-
Objective In order to investigate the reversibility of uremia in patients with lupus nephritis(LN). Methods 37 uremic patients with IN who underwent dialysis were treated with a progressive protocol of combined glucocorticoid and cyclophosphamide (CTX) during the last 15 years. Results 83.8% of patients withdrawed from dialysis, with an average withdrawal period of 40.6 ?21.5 months, and with serum creatinine of 179.36 ?88.24 fjiaoVL at least half year after the withdrawal. Conclusion Uremic patients with LN who should be dialysed are not necessarily in end stage of their renal diseases, and those who are indicated for immunosuppressants and probable to be reversed should be treated properly and promptly.